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Dropping anchor: attachment of 
peptidylarginine deiminase via 
A-LPS to secreted outer membrane 
vesicles of Porphyromonas 
gingivalis
Giorgio Gabarrini  1,2, Rick Heida2, Nienke van Ieperen2, Mike A. Curtis3, Arie Jan van 
Winkelhoff1,2 & Jan Maarten van Dijl2
The periodontal pathogen Porphyromonas gingivalis has been invoked in the autoimmune disease 
rheumatoid arthritis (RA). This association relates to the peptidylarginine deiminase of P. gingivalis 
(PPAD), an enzyme capable of citrullinating human proteins and potentially contributing to loss of 
tolerance to citrullinated proteins in RA. PPAD is both retained in the outer membrane (OM) of P. 
gingivalis cells and secreted into the extracellular milieu, where it is detected in a soluble form and in 
association with outer membrane vesicles (OMVs). Recent studies showed that certain P. gingivalis 
proteins are retained in the OM through modification with an A-type lipopolysaccharide (A-LPS). Here, 
we investigated the possible involvement of A-LPS modification in the association of PPAD to the 
OM and OMVs. The results indicate that the OM- and OMV-associated PPAD is A-LPS-modified. The 
modified PPAD species is of low abundance in particular clinical isolates of P. gingivalis, which is not 
due to defects in the overall synthesis of A-LPS-modified proteins but, rather, to particular traits of the 
respective PPAD proteins. Lastly, we show that OMV association protects the A-LPS-modified PPAD 
from proteolytic degradation. Altogether, our observations show that A-LPS modification contributes 
to OM(V) sorting and ‘protective secretion’ of PPAD.
Porphyromonas gingivalis is an anaerobic Gram-negative bacterium and keystone oral pathogen1,2 that is mostly 
known for its role as a causative agent of the inflammatory disease periodontitis3. In recent years, this bacterium 
has garnered interest for its alleged involvement in the etiopathogenesis of the autoimmune disease rheumatoid 
arthritis (RA)4–9. A symptom and possible cause for the disease RA is the loss of tolerance to citrullinated host 
proteins7,10–12. Accordingly, the discovery of a peptidylarginine deiminase in P. gingivalis (PPAD) was a turning 
point in the study of the etiology of RA, because this enzyme is capable of citrullinating certain host proteins. 
In turn, this might cause the production of anti-citrullinated protein autoantibodies (ACPAs), which are highly 
specific for RA13,14. This notion, coupled with the knowledge that periodontitis is clinically associated with RA, 
suggests a role for PPAD and therefore P. gingivalis in the etiology of rheumatoid arthritis and highlights the 
importance of studies on PPAD7,10. Specifically, understanding the localization of PPAD would ease the search for 
its targets and cofactors, rendering the sorting a paramount tool to further the knowledge of the molecular role of 
this virulence factor in the origin of RA.
Interestingly, three topological species of PPAD can be distinguished: a form bound to the outer membrane 
(OM)15–17, a form bound to secreted outer membrane vesicles (OMVs)18 and a secreted form that is present in 
a soluble state17,19–21. This relates to the particular features of the type IX secretion system, which is responsible 
for the secretion of PPAD and ~30 other OM proteins possessing the same recognition sequence, referred to as 
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‘C-terminal domain’ (CTD)22–24. During export these proteins are subject to post-translational modifications, 
including attachment to the OM via an A-lipopolysaccharide (A-LPS) anchor15,23,25,26. Although this has not yet 
been shown specifically, a modification with A-LPS would also explain the binding of PPAD to the OM and its 
association with OMVs. In this respect, it should be noted that OMVs are nanostructures resulting from outer 
membrane ‘blebbing’. Such OMVs are generally used by Gram-negative bacteria to secrete proteins, or to shuttle 
their cargo to cells or tissues of the host for infection purposes2,18. PPAD, in fact, has been reported to be present 
in OMVs together with several other virulence factors of P. gingivalis18,20. Of note, our recent studies indicate that 
two PPAD sorting types can be distinguished amongst clinical isolates of P. gingivalis20. Sorting type I isolates 
produce a dominant OMV-associated PPAD species and relatively lower amounts of the soluble secreted PPAD. 
In contrast, sorting type II isolates produce restricted amounts of the OMV-associated form of PPAD and sub-
stantially higher amounts of the soluble secreted form of PPAD20. This difference does not relate to differences 
in the amounts of PPAD or OMVs produced but, instead, it is correlated with the presence of an amino acid 
substitution at position 373 in the PPAD amino acid sequence. PPAD of sorting type I isolates has a Gln residue at 
position 373, whereas PPAD of sorting type II isolates has a Lys residue at this position20 (Fig. 1).
In view of the likely importance of A-LPS-modification in the subcellular localization of OM- and 
OMV-associated proteins, and the importance of PPAD as a virulence factor, the present study was aimed at 
assessing the extent to which PPAD of P. gingivalis is A-LPS-modified.
Materials and Methods
Bacterial strains and culture conditions. 16 P. gingivalis isolates were obtained from patients with a 
periodontal diagnosis (Table S1). Additionally, the study included two P. gingivalis type strains (W83 and ATCC 
33277). For comparison, a clinical Escherichia coli isolate was included (Table S1). P. gingivalis strains were grown 
anaerobically in Brain Heart Infusion (BHI) broth as previously described27; cultures were inoculated with 4 days 
old colonies on blood agar plates. The E. coli strain was cultured aerobically in Lysogeny Broth (LB) at 37 °C and 
with shaking (250 rpm), or on LB agar at 37 °C.
Ethics statement. The bacterial samples used in the present analyses were obtained in a previous study 
upon written informed consent4–8. This previous study received Institutional Review Board approval from the 
Medical Ethics Committee of the University Medical Center Groningen (METc UMCG 2011/010). It was per-
formed in accordance with the guidelines of the Declaration of Helsinki and the institutional regulations, and all 
samples were anonymized.
Immunoblot analyses. To collect secreted proteins of P. gingivalis, cells were separated from the growth 
medium by centrifugation and proteins in the growth medium fraction were precipitated with 10% trichlo-
roacetic acid (TCA) as previously described27. The collected cells were washed twice with phosphate buffered 
saline (PBS) to ensure absence of supernatant residues, and frozen at −20 °C. After having been thawed, the cells 
were resuspended in 300 μL of loading buffer, consisting of lithium dodecyl sulphate (LDS) sample buffer 4× 
(Life Technologies, Carlsbad, CA, USA), and sample reducing agent 10× (Life Technologies) in MilliQ water. 
Subsequently, glass beads (Biospec products, Bartlesville, OK, USA) were added to the cells to allow membrane 
disruption with a Precellys®24 Technology tissue homogenizer (Bertin instruments, Montigny-le Bretonneux, 
France) in three cycles of 30 sec at 6500 rpm with 30 sec breaks in between. Afterward, the glass beads and cellular 
debris were pelleted by centrifugation at 16100 × g, 4 °C for 10 min, and 100 μL of the supernatant were collected 
and boiled for 10 min at 95 °C. Subsequently, both the proteins from the secreted and the cell fractions were inves-
tigated by LDS polyacrylamide gel electrophoresis (PAGE) using NuPAGE gels from Life Technologies27.
The isolation of OMVs by ultracentrifugation of growth medium fractions was performed as previously 
described20,21. To disrupt OMVs mechanically, they were exposed to ultrasound in three cycles using a Misonix 
sonicator S-4000 (amplitude of 80, pulse-on for 15 seconds, pulse-off for 45 seconds, for altogether 3 min of 
pulse-on time per cycle) prior to precipitation with 10% TCA. To prevent protein degradation, cOmplete Mini 
protease inhibitors (Roche, Basel, Switzerland) were added immediately prior to sonication, according to manu-
facturer’s specifications.
Western blotting analysis was performed as described previously20, using Amersham™ Protran® 0.45 μm 
nitrocellulose membranes (GE Healthcare Life Sciences, Little Chalfont, Buckinghamshire, UK) and antibod-
ies specific for either P. gingivalis A-LPS (mAb1B5)28, or PPAD (GP2448)20. Membranes were washed with 
PBS-Tween20 (PBS-T) after overnight incubation with 5% skim milk in PBS, and incubated with primary 
Figure 1. PPAD sorting types are defined by an amino acid substitution at position 373. The PPAD protein of 
P. gingivalis comprises four domains, from N- to C-terminal end: the signal peptide (SP), the catalytic domain, 
the Ig-like fold (IgLF), and the C-terminal domain (CTD) as previously defined34. PPAD sorting type I isolates 
possess a Gln residue at position 373, while sorting type II isolates display a Lys residue in that same position20. 
The Gln and Lys residues at position 373 are marked in red. Also indicated are other substitutions that do not 
invariably occur in PPAD proteins from sorting type I or II isolates.
www.nature.com/scientificreports/
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anti-PPAD or A-LPS antibodies in a 1:10000 dilution. After one-hour incubation, membranes were washed four 
times for 5 min with PBS-T prior to 45 min incubation with IRDye® 800CW conjugated goat anti-mouse or goat 
anti-rabbit secondary antibodies (LI-COR Biosciences, Lincoln, NE, USA) at a 1:10000 dilution. When it was 
necessary to probe a blot with the mAb1B5 monoclonal antibody and a rabbit antibody at the same time, IRDye® 
680RD Goat anti-Rabbit IgG (LI-COR) was used as a secondary antibody instead of the IRDye® 800CW conju-
gated goat anti-rabbit antibody. Subsequently, membranes were washed four times in PBS-T and twice in PBS, 
before analysis with an Odyssey Infrared Imaging System (LI-COR Biosciences).
Aqueous two-phase system protein purification. To assess modification of the ~75–85-kDa PPAD 
species with A-LPS, a protein phase separation assay was applied using the non-ionic detergent Triton X-114 
(Sigma-Aldrich, St. Louis, USA)29. The cells present in 2.5 OD600 units of culture were collected via centrifu-
gation at 16100 × g 4 °C for 10 min, and resuspended in 300 μL of TEPI buffer, which is composed of TE buffer 
(Sigma-Aldrich) supplemented with 1 tablet of the cOmpleteTM Mini Protease Inhibitor Cocktail (Roche 
Diagnostics GmbH, Mannheim, Germany) per 10 mL. The growth medium fraction was put aside for later use. 
The cell fraction was vortexed with glass beads four times for one min, with 1-min intervals on ice, before the 
supernatant fraction containing soluble cellular and OM proteins was collected via centrifugation. The pellets 
containing glass beads and unbroken cells were washed twice with 300 μL of TEPI buffer and centrifuged. All 
supernatant fractions with soluble cellular and OM proteins were pooled. Subsequently, 100 μL of Triton X-114 
were added to both this pooled fraction with cellular proteins, and to the growth medium fraction. Upon brief 
vortexing, the Triton X-114-containing samples were incubated for 20 min at 4 °C. Prior to centrifugation at 
16100 × g and 4 °C for 5 min bromophenol blue (Bio-Rad Laboratories, Richmond, CA, USA) was added to the 
samples for a better visualization of phase separation in the subsequent steps. Next, the resulting supernatant was 
overlaid on a 200-μL cushion of 6% (w/v) sucrose (Boom B.V., Meppel, the Netherlands), 10 mM Tris-HCl, pH 
7.4, 150 mM NaCl, and 0.06% Triton X-114 to provide a better phase separation. The samples were then heated 
for 20 min at 37 °C for phase separation, and the separated phases were collected by centrifugation at 400 × g for 
3 min. To reduce phase contamination, only part of the aqueous phase (800 μL) and part of the detergent phase 
(90 μL) were collected. The remaining phases were extracted again by adding 90 μL of Triton X-114 to the aqueous 
phase and 800 μL of TEPI buffer to the detergent phase. Subsequently, proteins in the samples were precipitated 
with TCA (10% final concentration) by incubation on ice for 30 min. Afterward, the precipitated proteins were 
collected by centrifugation at 16100 × g, 4 °C for 10 min, washed twice with 500 μL of ice-cold acetone, dried at 
60 °C for 10 min, separated by LDS-PAGE and analyzed by Western blotting27.
LPS isolation. Isolation and analysis of LPS of P. gingivalis and E. coli was performed essentially as described 
by Geurtsen et al.30. For each sample, one OD600 unit was collected through centrifugation and resuspended in 
50 µL of 2× sample buffer31 (4% SDS, 20% glycerol, 120 mM Tris-HCl, 0.02% bromophenol blue) before incuba-
tion with 50 µL of 1 mg/mL proteinase K for 1 h at 55 °C. Subsequently, the proteinase K was inactivated for 10 min 
at 95 °C, and samples were diluted ten-fold. 2 µL of the diluted and 2 µL of the undiluted samples were loaded into 
a Tricine-SDS-polyacrylamide gel. Gels were run at 35 V for the stacking gel part and 105 V for the separation 
gel part. The separation gel was then fixed overnight in fixing buffer (40% ethanol, 5% acetic acid). Afterward, 
the gel was incubated, shaking at 40 rpm, in oxidizing buffer (40% ethanol, 5% acetic acid, and 0.7% periodic 
acid) for 5 min, prior to being washed thrice, in a clean dish, with demineralized water, shaking at 40 rpm, 15 min 
per wash. Subsequently, the gel was stained with staining reagent (1.33% ammonium hydroxide, 20 mM NaOH, 
0.66% silver nitrate (w/v)) for 10 min at 70 rpm. Lastly, the gel was washed thrice with demineralized water in a 
clean dish for 10 min at 40 rpm prior to incubation at 40 rpm with formaldehyde developer (50 mg citric acid and 
0.5 mL 37% formaldehyde per liter) until browning of LPS bands (2–5 min). Development was terminated using 
5% acetic acid.
Results
Distinction of Triton X-114- and water-soluble forms of PPAD. To investigate to what extent 
PPAD exists in hydrophobic and water-soluble states both within P. gingivalis cells and the growth medium, we 
established an approach for two-phase protein separation based on the non-ionic detergent Triton X-114. This 
approach relies on the principle that mixtures of Triton X-114 and water separate into an aqueous and a deter-
gent-rich phase upon heating above the cloud point of Triton X-114. Accordingly, membrane-associated hydro-
phobic proteins solubilized in mixtures of Triton X-114 and water will segregate into the detergent phase upon 
heating, while water-soluble proteins will segregate into the aqueous phase. For validation, this approach was 
applied to four clinical P. gingivalis isolates showing extreme PPAD sorting type I and II phenotypes. Upon phase 
separation, a Western blotting analysis was performed using the polyclonal PPAD-specific antibody GP2448. As 
shown in Fig. 2, this revealed distinct fractionation profiles for PPAD produced by sorting type I and II isolates. 
Firstly, a thick ~75–85-kDa band, that according to literature data17 represents the OM-bound PPAD, was present 
as a dominant species in the Triton X-114 phase of the cell fraction of the sorting type I isolates 20664 and 20665. 
Small traces of the ~75–85-kDa band could also be found in the aqueous phase of the cell fraction, but this was 
most likely due to phase contamination. This fractionation pattern is consistent with the previously proposed 
A-LPS modification of the ~75–85-kDa form of PPAD15,23. Further, we have shown previously that this form of 
PPAD is also detectable in association with secreted OMVs20. Consistent with our previous finding, the present 
analysis showed that the ~75–85-kDa OMV-associated form of PPAD of sorting type I isolates fractionated with 
the Triton X-114 phase of growth medium samples. In contrast, a predominantly cell-associated ~60-kDa form of 
PPAD as well as a secreted form of ~47-kDa fractionated with the aqueous phase (Fig. 2). This is consistent with 
the view that the ~60-kDa form represents an unprocessed version of PPAD that still possesses the CTD20, while 
the ~47-kDa form represents the soluble secreted PPAD17,20.
www.nature.com/scientificreports/
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For the clinical P. gingivalis sorting type II isolates MDS33 and 20663, a completely different PPAD frac-
tionation pattern was observed. The cell and growth medium fractions of both isolates completely lacked the 
~75–85-kDa form of PPAD (Fig. 2). Like the sorting type I isolates, cells of both sorting type II isolates contained 
the water-soluble ~60-kDa form of PPAD, which was absent from the growth medium. Further, both sorting type 
II isolates produced the ~47-kDa secreted form of PPAD, similar to the type I isolates. However, in contrast to the 
sorting type I isolates, both sorting type II isolates produced a ~37-kDa form of PPAD that was detectable both 
in the cell and growth medium fractions. This ~37-kDa is too small in size to represent an intact form of PPAD. 
Intriguingly, upon two-phase protein separation, this ~37-kDa form of PPAD did not clearly segregate between 
the Triton X-114 and the aqueous fractions.
A-LPS anchors PPAD to the outer membrane. To verify that A-LPS is the anchor that binds PPAD to 
the OM, we performed a Western blotting analysis on the cell fractions of P. gingivalis isolates of sorting type I 
and II divided in two phases by two-phase protein separation with Triton X-114. The presence of A-LPS was visu-
alized using the A-LPS-specific monoclonal antibody mAb1B528,32. As shown in Fig. 3, the A-LPS-modified pro-
teins were detected as a very broad pattern of closely migrating bands, rather than distinct individual bands. This 
was to be expected considering that ~30 different proteins of various sizes appear to be anchored to the OM via 
A-LPS15. Furthermore, the bulk of the A-LPS-specific signals were detected in the Triton X-114-rich phase, con-
sistent with the notion that lipidated molecules of P. gingivalis, such as A-LPS-modified proteins, should fraction 
in the detergent-phase. Significantly lower amounts of A-LPS-modified proteins were detected in the aqueous 
phase, most likely as a result of phase contamination. Of note, the overall fractionation profile of A-LPS-modified 
proteins was independent of the PPAD sorting type of the investigated P. gingivalis isolates. Further, a thick 
A-LPS-containing band of ~75-kDa was observed in samples of the P. gingivalis strain W83, which belongs to the 
PPAD sorting type I (Fig. 3A, marked by a box). Since this could potentially represent the A-LPS-modified species 
of PPAD, we repeated the analysis using both the A-LPS-specific mAb1B5 monoclonal and the PPAD-specific 
GP2448 rabbit antibody, the binding of which can be distinguished with differently labeled secondary antibod-
ies. Accordingly, the A-LPS-specific signal in Fig. 3B is represented in green and the PPAD-specific signal in 
red, while overlaps between the two signals are represented in yellow-orange. Indeed, the A-LPS-specific green 
signal was predominantly detected in the detergent-rich phase, with a clear yellow-orange signal marking the 
position of the ~75–85-kDa band of PPAD in samples of the PPAD sorting type I strains 505774, 20664 and W83. 
Additionally, the cell-associated ~60-kDa PPAD species was clearly detectable as a red band in the aqueous phase, 
especially in the case of the sorting type I strain 20664 and the sorting type II strains MDS33. The ~37-kDa PPAD 
species, instead, was detected as a red band in samples of the PPAD sorting type II isolates, where it was present 
predominantly in the detergent-rich phase but also in the aqueous phase (Fig. 3B). These findings indicate that 
the PPAD molecules in the ~75–85-kDa band are A-LPS-modified, while the PPAD molecules in the ~60-kDa 
and ~37-kDa bands contain little, if any A-LPS.
Figure 2. Triton X-114 solubility of different cell-associated and secreted PPAD species. P. gingivalis 
isolates were cultured in BHI, and the cell and growth medium fractions were separated by centrifugation. 
Subsequently, both fractions were extracted with Triton X-114. Upon phase separation at 37 °C, proteins in the 
different detergent-rich (T) and aqueous (A) phases were analyzed by LDS-PAGE and Western blotting with 
PPAD-specific antibodies. Names of PPAD sorting type I isolates are underlined. Molecular weights of marker 
proteins and different PPAD species are indicated. The full-length blot is presented in Figure S1.
www.nature.com/scientificreports/
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PPAD sorting in sorting type II isolates. We have previously shown that sorting type II P. gingivalis 
isolates secreted very low levels of the ~75–85-kDa OMV-associated PPAD species compared to sorting type 
I strains20. Since the ~75–85-kDa species of PPAD seems to be A-LPS-modified, it was of interest to investi-
gate whether the sorting type II isolates of P. gingivalis do produce similar levels of A-LPS-modified proteins 
as the sorting type I isolates. This is indeed the case for both the cell-associated and the secreted proteins of 
eight sorting type II isolates, as was shown by Western blotting with the A-LPS-specific antibody (Fig. 4; 
potentially A-LPS-modified proteins are represented in green). Of note, simultaneous immunodetection of 
PPAD indicates that the dominant PPAD species in the growth medium of these isolates was the unmodified 
~37-kDa species (represented as a red band in Fig. 4). Of note, the secreted ~47-kDa species has a yellow-orange 
appearance in Fig. 4. This most likely relates to its relatively low abundance in the respective molecular weight 
range of A-LPS-modified proteins. Consistent with the results presented in Fig. 3B, the ~75–85-kDa OM- and 
OMV-bound PPAD species were displayed significantly only by the sorting type I control isolate 20664 in the cell 
and growth medium fractions, respectively.
To exclude any possible differences in the LPS produced by PPAD sorting type I and II isolates, the total LPS 
of the sorting type II isolate 512915 was compared to that of the P. gingivalis type strains W83 and ATCC 3277, 
which represent the PPAD sorting type I. No differences in the LPS species of these three P. gingivalis isolates were 
detectable by SDS-PAGE and subsequent silver-staining (Fig. 5). In contrast, the LPS extracted from the three P. 
gingivalis isolates differed substantially from that of an E. coli control isolate. Together, these findings show that 
both the PPAD sorting type I and II isolates produce similar amounts of LPS in general and A-LPS-modified 
proteins in particular.
Intact OMVs protect A-LPS-modified PPAD against proteolysis. To investigate whether the 
OMV-associated A-LPS-modified PPAD can be liberated from the OMVs by mechanical disruption of the OMVs, 
we subjected the OMVs of different PPAD sorting type I and II isolates to sonication. In particular, OMVs were 
isolated from the growth medium by ultracentrifugation, exposed to three cycles of sonication, and the resulting 
fractions were analyzed by LDS-PAGE and Western blotting with PPAD-specific antibodies. Surprisingly, the 
results shown in Fig. 6A revealed that the PPAD had largely disappeared from the sonicated OMV fraction. To 
determine whether this was due to degradation by proteases secreted by P. gingivalis, the experiment was repeated 
in the presence of a protease inhibitor cocktail. Indeed, the addition of protease inhibitors precluded PPAD deg-
radation during sonication (Fig. 6B), showing that secreted proteases of P. gingivalis were capable of degrading 
A-LPS-modified PPAD when the OMV integrity was violated by ultrasound. To assess whether the protection by 
Figure 3. A-LPS modification of PPAD in sorting type I and II isolates of P. gingivalis. Cells of P. gingivalis 
sorting type I and II isolates were cultured in BHI and, subsequently, extracted with Triton X-114. Upon phase 
separation at 37 °C, proteins in the detergent-rich (T) and aqueous (A) phases were analyzed by LDS-PAGE and 
Western blotting. In panel A immunodetection was performed with an A-LPS-specific monoclonal antibody. 
Panel B shows a dual-labeling image upon immunodetection with the A-LPS-specific monoclonal antibody 
(green signal) and a PPAD-specific rabbit antibody (red signal). Bands representing the A-LPS-modified 
PPAD species of ~75–85-kDa PPAD are boxed in both panels. Names of sorting type I isolates are underlined. 
Molecular weights of marker proteins are indicated. The full-length blot is presented in Figure S1. Please note 
that the order of ‘A’- and ‘T’-labeled lanes is inversed compared to Fig. 2 as samples were loaded in a different 
order.
www.nature.com/scientificreports/
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OMVs was specific for PPAD, the samples from Fig. 6A were also analyzed by Western blotting with antibodies 
specific for the known OMV cargo protein Omp4120. As shown in Fig. 6C, for most investigated isolates, relatively 
little degradation of Omp41 was detectable upon sonication, even in the absence of protease inhibitors. In the 
case of isolates 513324 and 513163, also substantial degradation of Omp41 was observed upon OMV sonica-
tion, suggesting that these isolates are either more proteolytic than other isolates or that the respective Omp41 
proteins are more susceptible to proteolysis than those of other isolates. Altogether, these observations imply 
that A-LPS-modified PPAD specifically requires the OMV environment for ‘protective secretion’ into the highly 
proteolytic extracellular milieu of P. gingivalis.
Figure 4. Detection of A-LPS-modified proteins in PPAD sorting type II isolates. P. gingivalis was cultured 
in BHI and, subsequently, the cells and growth medium fractions were separated by centrifugation. Proteins 
in both fractions were separated by LDS-PAGE and analyzed by Western blotting using an A-LPS-specific 
monoclonal antibody (green signal) and a PPAD-specific antibody (red signal) as indicated for Fig. 3. The name 
of the PPAD sorting type I isolate used as a control is underlined. Molecular weights of marker proteins are 
indicated. The full-length blot is presented in Figure S1.
Figure 5. LPS fingerprints of PPAD sorting type I and II isolates. Total LPS was extracted from P. gingivalis 
sorting type I and II isolates, and an E. coli control. Subsequently, the extracted LPS was separated by SDS-PAGE 
and visualized by silver staining. To detect possible differences in the fingerprints, extracted LPS was loaded in 
a ten-fold dilution and undiluted. Names of sorting type I isolates are underlined. The full-length gel picture is 
presented in Figure S1.
www.nature.com/scientificreports/
7SCientifiC RePoRTS |  (2018) 8:8949  | DOI:10.1038/s41598-018-27223-5
Discussion
Based on PPAD’s status as a P. gingivalis virulence factor and its potential as a key factor bridging periodontitis 
and the etiopathogenesis of RA, we investigated its attachment to the OM and OMVs of P. gingivalis. Previous 
studies have shown that A-LPS is the anchor for proteins secreted by the type IX secretion system. PPAD is also 
one of the proteins secreted via the type IX system and the present study was, therefore, aimed at verifying the 
A-LPS-modification of PPAD attached to the OM and OMVs.
Our results show the presence of different PPAD species that are differentially sorted in P. gingivalis. Firstly, a 
soluble, secreted, ~47-kDa species of PPAD17,20 was detected in both sorting type I and II isolates in comparable 
amounts and not attached to lipids. Interestingly, an alleged A-LPS-modified OM-bound and OMV-bound ~75–
85-kDa PPAD species17,20 could be detected in PPAD sorting type I isolates and, in severely reduced amounts, also 
in PPAD sorting type II isolates. Notably, the band representing this species was most prominently detected in the 
growth medium fraction compared to the cell fraction, which appears to relate to a higher A-LPS density in the 
OMVs, compared to the outer membrane of the cell33. A PPAD species of ~60-kDa was displayed by both sorting 
type I and II isolates. This PPAD species fractionated with the aqueous phase of cells treated with the detergent 
Triton X-114, which suggests that it could be localized to the periplasm of P. gingivalis. In turn, this would imply 
that the ~60-kDa species represents an unprocessed, uncleaved form of PPAD, as was suspected based on its size 
and solubility20,21. Lastly, a ~37-kDa PPAD species was observed only in sorting type II isolates. Upon Triton 
X-114 extraction, this ~37-kDa form of PPAD did not clearly segregate between the detergent and the aqueous 
fractions. This suggests that the ~37-kDa form represents two similarly-sized degradation products of PPAD with 
different hydrophobicity. For example, the hydrophobic form of the ~37-kDa that could represent a derivative of 
the ~75–85-kDa species. In this respect, it is noteworthy that the PPAD sorting type II phenotype is associated 
with a Gln to Lys substitution at residue 373, which is exposed to the surface of PPAD20. The presence of this Lys 
Figure 6. Protective secretion of OMV-associated A-LPS-modified PPAD. P. gingivalis was cultured in BHI 
and, subsequently, the cells and growth medium fractions were separated by centrifugation. Next, OMVs were 
collected from the growth medium fraction by ultracentrifugation, and part of the collected OMV fraction was 
subjected to sonication either in the absence (A,C) or presence (B) of protease inhibitors. Proteins from the 
growth medium fraction, intact OMVs and sonicated OMVs were separated by LDS-PAGE and analyzed by 
Western blotting using a PPAD-specific antibody (A,B) or an Omp41-specific antibody (C). Names of sorting 
type I isolates are underlined, and molecular weights of marker proteins are indicated. The full-length blots are 
presented in Figure S1. The band of 21 kDa labeled X represents an unidentified protein that cross-reacts with 
the Omp41-specific antibody, possibly a degradation product of Omp41.
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residue at the membrane surface could make PPAD proteins with the sorting type II susceptible to cleavage by the 
secreted lysine-specific gingipain (Kgp) of P. gingivalis, which might explain the presence of the ~37 kDa PPAD 
species.
To verify whether PPAD binding to the OM and OMVs involves an A-LPS anchor, we made use of the 
mAb1B5 antibody28,32, which was raised specifically against P. gingivalis A-LPS. Upon probing with both mAb1B5 
and a PPAD antibody, we discovered that a strong A-LPS signal at around 75-kDa aligns with the PPAD signal at 
this position in the Western blot. This supports the view that the ~75–85-kDa PPAD species fractionating with 
the detergent Triton X-114 is A-LPS-modified. Conversely, Western blotting with mAb1B5 indicates that the 
soluble ~60-kDa form of PPAD does not contain A-LPS, consistent with the periplasmic localization as proposed 
above. Together, these data allow us to correlate the differentially stained A-LPS and PPAD bands in Figs 3B and 4, 
in particular because the 75–85 kDa species of PPAD is nearly completely absent from the PPAD sorting type II 
cells and growth medium fractions. Importantly, the Western blotting analysis with mAb1B5 demonstrated the 
presence of comparable amounts of potentially A-LPS-modified proteins in all investigated P. gingivalis isolates, 
regardless of their PPAD sorting type. This shows that the PPAD sorting types I and II are not distinguished by 
differences in the overall A-LPS modification of proteins. Further proof of this view was obtained by the analysis 
of total LPS extracted from cells with different PPAD sorting types, which showed no detectable differences.
Lastly, by subjecting OMVs of either PPAD sorting type to sonication, the A-LPS-modified PPAD became sus-
ceptible to proteolysis. On this basis, we conclude that the A-LPS-modification serves not only to localize PPAD 
to OMVs but also to place it in a position where it is protected from proteolysis by the highly active secreted 
proteases of P. gingivalis, including arginine- and lysine-specific gingipains. Whether this means that the OMV 
association segregates the A-LPS-modified PPAD physically from the secreted proteases, or whether particular 
protease cleavage sites are protected by the OMVs remains to be determined. This is a relevant question for future 
studies, because a previous study has shown that gingipains are also detectable as cargo of OMVs from P. gingiv-
alis strain W5018. Of note, these previous results indicated that the gingipains were predominantly exposed on the 
OMV surface, but absent from the OMV lumen18.
Taken together, the present findings correlate A-LPS-modification of PPAD with the anchoring of this protein 
to the OM and OMVs of P. gingivalis. Additionally, they show that there are no differences in the overall A-LPS 
synthesis or overall A-LPS modification of exported proteins in PPAD sorting type I and II isolates. This supports 
the notion that Gln373 of PPAD is critical for A-LPS modification, and that the Q373K substitution encountered 
in the PPAD of sorting type II isolates hinders the A-LPS modification of this important virulence factor. It is 
currently not known whether the difference in A-LPS modification and PPAD sorting observed in the type I and 
II P. gingivalis isolates may have clinical implications for periodontitis and RA. Both PPAD sorting types I and II 
have been found in at least one periodontitis patient with RA and at least one periodontitis patient without RA. 
This leads us to believe that the PPAD sorting type is not a decisive, tipping factor for triggering RA. However, 
considering the fact that RA is a multifactorial disease and that patient data on the analyzed isolates were in most 
cases incomplete with respect to the diagnosis of RA, it is presently impossible to draw conclusions on possible 
implications of the PPAD sorting type in relation to RA.
Ethics. The present research has no particular ethical implications.
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